Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to explore lymph node metastasis in the short gastric mesentery following total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision, providing evidence-based medicine for standardizing lymph node dissection in gastric cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Aged older than 18 years and younger than 85 years

• Primary gastric adenocarcinoma confirmed by preoperative pathology result

• cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition

• Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision

• American Society of Anesthesiologists (ASA) class I, II, or III

• Written informed consent

Locations
Other Locations
China
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING
Hangzhou
Contact Information
Primary
Tao Wang, Ph.d
15002740874@163.com
+86-197-068-25286
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 150
Treatments
Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision
No additional intervention is imposed on patients except normal clinical diagnosis and treatment.
Sponsors
Leads: Jichao Qin

This content was sourced from clinicaltrials.gov